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ABSTRACT
Background Understanding myocardial infarction (MI) incidence and case fatality trends across the four UK constituent countries is of
importance following devolution of the government of health-care services.
Methods Retrospective cohort study using a primary care database (5.19 million patients) examining trends in incidence of first MI and
30-day case fatality.
Results From 1996 to 2005, the incidence of MI decreased in all countries, but reductions were greater in England (men, 23.1%; women,
22.8%) and Wales (men, 23.3%; women, 24.6%) than in Scotland (men, 21.9%; women, 20.6%) and Northern Ireland (men no
change, women, 20.8%) (average annual percentage change). Greater reductions in England and Wales than Scotland and Northern Ireland
meant a widening of north–south difference in MI incidence over the study period. Downward trends in 30-day case fatality were found in
each country but less regional variation was evident (England men, 212.0%, women, 211.0%; Wales men, 218.4%, women, 212.6%;
Scotland men, 29.5%, women, 29.0%; Northern Ireland men, 28.6%, women, 213.0%).
Conclusion From 1996 to 2005, downward trends in the incidence of first MI and 30-day case fatality were evident in each constituent
country. Greater improvements in case fatality, compared with incidence, were found within each country.
Keywords case fatality, incidence, myocardial infarction, trends, United Kingdom
Introduction
Acute myocardial infarction (MI) is the major cause of cor-
onary heart disease (CHD) morbidity and mortality. Each
year in the UK, there are approximately 67 000 MIs in men
and 46 000 MIs in women of all ages,1 but there is little
information available on constituent country differences in
incidence and case fatality, or how these differences may
have changed over time.1–3
Over the past two decades, marked declines in acute coron-
ary event rates and 1-month case fatality have been reported in
some UK populations. For example, annual relative declines in
MI incidence between 2 and 4% per year since the early 1980s
were noted among men and women in Belfast and Glasgow.4
The British Regional Heart Study reported a 3.5% age
adjusted annual relative decline in the incidence of ﬁrst major
CHD event (including fatal and non-fatal MI and cardiac
death) among men from 1978/80 to 1998/2000,
accompanied by a 1.4% annual relative decline in 28-day case
fatality.5 The Scottish Morbidity Record Database also
reported evidence of marked declines in 30-day case fatality in
men and women in Scotland between 1986 and 1995.6
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Since 1998, government of health services across the UK
has been devolved to each of the four constituent
countries,7–10 and this has lead to different National Service
Frameworks for CHD in England,11 Wales12 and
Scotland.13 Understanding of the extent of geographical
variations in MI incidence and case fatality relies upon com-
paring results from a number of individual studies carried
out in localized areas of the UK. Comparison across studies
is difﬁcult due to the variety of case deﬁnitions and popu-
lations investigated.14,15 Furthermore, the majority of studies
were completed before the introduction of respective
National Service Frameworks for CHD11–13 and may not
reﬂect current CHD trends at a constituent country level.
Using data from a representative primary care database,16 we
examined trends in MI incidence and case fatality among men
and women in the four UK constituent countries, and changes
to constituent country differences over the period 1996–2005.
Methods
Data source
The Health Information Network (THIN) is a large primary
care database comprising patient data from general practices
(GPs) across the UK. The data extracted for this study was
from the version THIN314, which comprised data from 314
general practices, giving a combined total of 5.19 million
patients, representing approximately 3% of the UK popu-
lation. Approximately 50% of practices in THIN also report
to the General Practice Research Database (GPRD), a vali-
dated primary care database. A comparison of the strength of
established associations in THIN practices, which do not
report to GRPD and those which do, showed similar results.16
The prescription rate, general practitioner consultation rate,
pregnancy rate and death rate in THIN are comparable with
published estimates.17 The geographical distribution of the
adult population (.34 years) in THIN was comparable to the
UK population distribution in 1996, 2000 and 2006 (2000
ﬁgures: UK population 84% England, 5% Wales, 9%
Scotland, 4% North Ireland; THIN population 85% England,
5% Wales, 6% Scotland, 3% N Ireland).18 The age and sex dis-
tribution of each country’s THIN population was representa-
tive of the respective country’s population estimates.
Case definition
Read Clinical Classiﬁcation codes indicative of an incident MI
or a previous MI were selected by a clinician (L.S.) from a
wider list of CHD codes identiﬁed by the following criteria.
(i) Beginning G3% or Gyu3% (excluding aneurysm of
heart (G341%) and cardiac syndrome (G37%)).
(ii) Identiﬁed using the following keywords and their
derivatives: coronary, angina, MI, ischaemic, heart
attack, ischaemic chest pain, atherosclerotic.
(iii) Identiﬁed in the Department of Health CHD indicator
set.19
Mi incidence
All patients who had their ﬁrst MI after their index date (the
patient registration date or the date the GP was computerized
and contributing data) between 1 January 1996 and 31
December 2005 were selected (N ¼ 30,139). To control for
delayed recording of past MI events in newly registered patients,
patients whose ﬁrst MI was recorded within 30 days after regis-
tration were excluded (n ¼ 564, 1.9%).20 A sensitivity analysis
showed MI recording rates levelled after 30 days and it was not
necessary to exclude a longer period. Patients with a clinical
diagnosis indicating a history of MI recorded on or before the
ﬁrst incident MI (n ¼ 137, 0.5%) and those aged less than 35
years on their ﬁrst MI date (n ¼ 123, 0.4%) were also excluded.
Annual incidence was calculated as the number of patients
who had their ﬁrst MI recorded in each year divided by the
THIN mid-year adult (.34 years) population for that year.
Given the difﬁculty in choosing a relevant time period to
measure factors among non-MI patients, explanatory factors
for constituent country differences in MI incidence were not
examined.
30-day case fatality
The annual 30-day case fatality14 was calculated as the
number of patients who died within 30 days of their ﬁrst
MI in each year divided by the total number of patients who
had their ﬁrst MI in that year.
Case fatality may be under-estimated due to under-recording
of death in primary care. Within THIN, each practice has been
assigned a year from which death reporting is acceptable (by
comparing the observed number of deaths in the general prac-
tice with that expected, according to national mortality statistics
and the demographic structure of the practice).21 To prevent
survivor bias patients who had their ﬁrst MI event recorded
before the practice acceptable mortality reporting year were
excluded from the case fatality analysis (n ¼ 1723, 5.7%).
Examining determinants of geographic variations
in case fatality
Explanatory variables examined were: age group; history of
hyperlipidaemia, hypertension, renal disease, active liver
disease, CHD (clinical CHD diagnoses or an average of more
than one nitrate prescription per year), diabetes (medical dia-
betic event or prescriptions for diabetic medication (section 6.1
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of the British National Formulary22)); prescribed a lipid lower-
ing medication before the ﬁrst MI (section 2.12 of the British
National Formulary excluding dextrothyroxine sodium);
smoking and alcohol status (determined at patient index date);
body mass index (BMI); socio-economic deprivation quintile
(by assigning individual patient addresses (2006 data) to area
indicators of socio-economic deprivation derived from 2001
census information and available at the level of output area23).
Each variable was recorded for all patients with the
exception of smoking (33.5% missing), alcohol consumption
(11.8% missing), BMI (15.0% missing) and socio-economic
deprivation (17.9% missing).
Statistical analyses
Direct standardization was used to calculate the
age-standardized MI incidence and case fatality by applying
age group (35–39 etc. to 85þ years) speciﬁc risks stratiﬁed
by sex to the Ofﬁce for National Statistics 2004 population
estimates for the UK24 (incidence calculations), or the distri-
bution of ﬁrst MI cases in the UK in 2004 (THIN data)
(case fatality calculations). The average annual percentage
change in risk for age standardized rates (MI incidence and
case fatality as calculated above) was investigated using
Poisson regression using the denominator as the offset, and
the number of cases or events as the outcome, and includ-
ing calendar year as a continuous variable. In order to
smooth random ﬂuctuation over time, risks were calculated
as 3 yearly weighted averages (e.g. 1997 represents the
average age standardized risks from 1996 to 1998 calculated
as ((n1996 þ n1997 þ n1998)/(N1996 þ N1997 þ N1998)),
where n is the age standardized expected number of deaths
and N is the standard population denominator. Standard
errors and 95% conﬁdence intervals (CI) for the standar-
dized risks were calculated using standard methods.25
For the more detailed regional analysis over two time
periods (1996–2000 and 2001–2005) (i) Poisson regression
was used for the MI incidence outcome and (ii) logistic
regression for the case fatality outcome. All analyses were
stratiﬁed by gender. We carried out tests for interaction by
ﬁtting models that contained interaction terms of time with
constituent country. For both, multilevel (mixed effects
analysis) modelling was used to take into account patient
clustering within practices.26
Results
Incidence of first MI: trends and differences
between constituent countries
Between 1996 and 2005, 29 315 (62.1% male) patients diag-
nosed with their ﬁrst MI were identiﬁed. Downward trends
in the age standardized incidence risk of ﬁrst MI were
found in men and women in each constituent country, with
the exception of men in Northern Ireland. Temporal trends
were signiﬁcantly different in each region. The largest
declines in the age standardized incidence of ﬁrst MI were
found in Wales and England (Table 1). There was some evi-
dence of a downward trend in MI incidence in men and
women in Scotland and among women in Northern Ireland,
but the average annual relative percentage changes were
smaller than observed for Wales and England (Table 1).
In each year, over the period 1996–2005, the age standar-
dized incidence of ﬁrst MI was lower in Wales and England
compared with Scotland and Northern Ireland (Table 2). In
1996/2000, the age adjusted incidence risk among men in
Scotland and Northern Ireland was 24.8% (95% CI: 4.9–
48.6%) and 22.0% (95% CI: 22.7% to 53.0%), respectively,
greater than in England. In 2001–2005, this increased to
32.9% (15.3–53.2%) and 31.1% (8.3–58.7%), respectively
(Table 2). The change in risk ratio for men in Scotland com-
pared with England was statistically signiﬁcant (P ¼ 0.031).
A similar pattern was found among women, but these
changes were not statistically signiﬁcant when time-trends
across periods were compared between constituent countries
(Table 2).
30-day case fatality: trends and differences
between constituent countries
Of the 27 592 patients included in the case fatality analysis,
4336 (15.7%) died within 30 days of their ﬁrst MI.
Temporal trends were signiﬁcantly different in each region.
Steep downward trends in the age standardized 30-day case
fatality were evident in men and women in Wales, England
and Scotland. In England and Scotland the average annual
relative percentage decrease in case fatality was 10–12% per
year in men and women, but greater declines were found in
Wales (Table 1).
Results suggest a possible reduction in constituent
country differences in 30-day case fatality following ﬁrst MI
in patients diagnosed over the period 1996–2000 compared
with 2001–2005, as the odds ratios moved closer to the null
(Table 3). Signiﬁcant changes in the odds ratios over time
among men in Wales, compared with England, were found.
In 2001–2005 there was some evidence to suggest that the
odds of 30-day case fatality among men in Wales was lower
than in England, but some of this difference was accounted
for by area level deprivation and smoking status (Table 3).
Signiﬁcant changes in the odds ratios over time among
women in Northern Ireland, compared with England, were
also found (Table 3).
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Table 1 Age standardized myocardial infarction incidence and case fatality in 1996, 2000 and 2005 in the adult population (.34 years) and average annual percentage change from 1996 to 2005,
by constituent country and gender
Gender Constituent
country
Incidence of first MI 30-day case fatality
1996 Age
standardizeda
(per 1000 pop,
95% CI)
2000 Age
standardizeda
(percentage,
95% CI)
2005 Age
standardizeda
(per 1000 pop,
95% CI)
Average annual
percentage changeb
1996 Age
standardizedc
(percentage, 95% CI)
2000 Age
standardizedc
(percentage, 95% CI)
2005 Age
standardizedc
(percentage, 95% CI)
Average annual
percentage changeb
Men England 3.5 (3.4, 3.7) 3.2 (3.0, 3.3) 2.3 (2.2, 2.4) 23.1* (23.0, 23.2) 24.3 (22.0, 26.5) 12.3 (10.7, 13.9) 7.7 (6.2, 9.3) 212.0* (210.7, 213.2)
Wales 3.6 (2.9, 4.3) 3.1 (2.5, 3.7) 2.4 (1.9, 2.8) 23.3* (23.2, 23.4) 24.1 (14.5, 33.7) 15.7 (9.8, 21.6) 3.9 (20.3, 8.1) 218.4* (217.1, 219.7)
Scotland 4.4 (3.6, 5.1) 4.2 (3.6, 4.9) 3.0 (2.4, 3.5) 21.9* (21.9, 22.0) 25.3 (18.1, 32.5) 16.3 (10.5, 22.1) 10.2 (4.4, 16.0) 29.5* (28.4, 210.6)
Northern
Ireland
3.5 (2.6, 4.4) 3.4 (2.6, 4.2) 3.5 (2.7, 4.3) 0** (0, 0.1) 13.6 (4.3, 22.8) 15.0 (7.3, 22.7) 15.0 (7.3, 22.6) 28.6* (27.4, 28.6)
Women England 1.9 (1.7, 2.0) 1.6 (1.5, 1.7) 1.3 (1.2, 1.4) 22.8* (22.7, 22.9) 30.2 (27.1, 33.3) 16.4 (13.9, 18.9) 9.5 (7.7, 11.3) 211.0* (29.6, 212.4)
Wales 1.9 (1.5, 2.4) 1.7 (1.3, 2.1) 1.1 (0.8, 1.4) 24.6* (24.5, 24.7) 30.9 (16.2, 45.5) 30.2 (19.3, 41.1) 3.8 (21.5, 9.1) 212.6* (211.2, 214.0)
Scotland 2.3 (1.7, 2.8) 2.6 (2.1, 3.1) 2.2 (1.7, 2.6) 20.6* (20.5, 20.7) 37.4 (25.3, 49.6) 31.9 (22.3, 41.6) 17.2 (10.1, 24.3) 29.0* (27.7, 210.2)
Northern
Ireland
2.9 (2.1, 3.7) 2.2 (1.5, 2.8) 2.4 (1.8, 3.1) 20.8* (20.7, 20.9) 42.7 (29.4, 56.0) 35.4 (23.5, 47.2) 20.5 (10.5, 30.6) 213.0* (211.7, 214.3)
aAge standardized to the ONS UK 2004 population estimates (35 to 85þ years) using 5 yearly age groups (35 to 85þ years).
bFrom Poisson regression: average annual percentage change over the period 1996–2005 relative to the rate in 1996.
cAge standardized to the age and sex distribution of incident cases in the UK in 2004 in THIN using 5 yearly age groups (35 to 85þ years).
*P, 0.001, **P ¼ 0.324. Interaction between calendar year and constituent country: MI incidence men and women: P, 0.001, case fatality men and women: P, 0.001.
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Discussion
Main findings of this study
Between 1996 and 2005, downward trends in the incidence
of ﬁrst MI and 30-day case fatality were found in men and
women in all four UK constituent countries. The magnitude
of the decline in MI incidence was greater in England and
Wales than in Scotland and Northern Ireland, which may
reﬂect a widening of constituent country differences in MI
Table 3 Odds ratio for 30-day case fatality following first MI in adult (.34 years) men and women, comparing Wales, Scotland and Northern Ireland
to England, over the period 1996–2000 and 2001–2005
Time period 1996–2000 2001–2005
Constituent
country
Number
of deathsa
Odds ratiob (95% CI),
P-value
Adjusted odds ratioc
(95% CI), P-value
Number
of deathsa
Odds ratiob (95% CI),
P-value
Adjusted odds ratioc
(95% CI), P-value
Men England 1175 1 1 738 1 1
Walesd 68 1.02 (0.45, 2.32), 0.963 1.27 (0.58, 2.76), 0.548 33 0.58 (0.29, 1.19), 0.140 0.65 (0.29, 1.42), 0.280
Scotland 123 1.74 (0.90, 3.39), 0.101 1.35 (0.67, 2.74), 0.403 91 1.59 (0.90, 2.80), 0.112 1.73 (0.90, 3.34), 0.101
Northern
Ireland
51 1.51 (0.58, 3.90), 0.401 1.49 (0.59, 3.73), 0.395 34 0.82 (0.35, 1.94), 0.639 0.76 (0.29, 1.97), 0.572
Women England 979 1 1 648 1 1
Wales 52 1.00 (0.46, 2.16), 0.994 1.97 (0.81, 4.76), 0.132 43 0.95 (0.48, 1.90), 0.879 0.81 (0.35, 1.86), 0.621
Scotland 122 1.78 (0.95, 3.31), 0.071 1.90 (0.97, 3.72) 0.062 96 1.76 (1.00, 3.09), 0.050 1.52 (0.75, 3.10), 0.248
Northern
Irelande
54 1.95 (0.82, 4.62), 0.127 1.97 (0.81, 4.76), 0.132 29 0.90 (0.39, 2.09), 0.819 0.91 (0.33, 2.44), 0.837
a30-day case fatality.
bMultilevel logistic regression odds ratio and 95% CI for the odds ratio adjusted for calendar year and age group at first MI diagnosis.
cMultilevel logistic regression odds ratio and 95% CI for the odds ratio adjusted for calendar year, age group at first MI diagnosis, smoking status and
area socio-economic deprivation quintile.
dInteraction between the effect of period and the effect of Wales (relative to trends in England), adjusted for age group, P ¼ 0.067; adjusted for age
group, smoking status and area socio-economic deprivation quintile, P ¼ 0.048.
eInteraction between the effect of period and the effect of Northern Ireland (relative to trends in England) adjusted for age group P ¼ 0.001; adjusted
for age group, smoking status and area socio-economic deprivation quintile, P ¼ 0.022.
Table 2 Poisson risk ratio for the incidence of first MI in adult (.34 years) men and women, comparing Wales, Scotland and Northern Ireland to
England, over the period 1996–2000 and 2001–2005
Time period 1996–2000 2001–2005
Constituent country Number of first
incident MI events
Risk ratioa (95% CI) P-value Number of first
incident MI events
Risk ratioa (95% CI) P-value
Men England 7581 1 7436 1
Wales 503 1.06 (0.86, 1.30) 0.610 553 1.07 (0.91, 1.25) 0.436
Scotlandb 644 1.25 (1.05, 1.49) 0.012 730 1.33 (1.15, 1.53) ,0.001
Northern Ireland 345 1.22 (0.97, 1.53) 0.086 389 1.31 (1.08, 1.59) 0.005
Women England 4580 1 4360 1
Wales 339 1.19 (0.93, 1.53) 0.164 336 1.09 (0.90, 1.33) 0.366
Scotland 457 1.46 (1.18, 1.80) ,0.001 528 1.63 (1.37, 1.93) ,0.001
Northern Ireland 231 1.37 (1.04, 1.81) 0.024 260 1.52 (1.21, 1.91) ,0.001
aMultilevel Poisson regression risk ratio and 95% CI for the risk ratio adjusted for calendar year and age group.
bInteraction of period with the effect of Scotland (relative to trends in England): P ¼ 0.047.
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incidence. Whereas constituent country differences in 30-day
case fatality from 1996 to 2005 were reduced.
Over the period 1996–2005, declines in age standardized
incidence of ﬁrst MI in men and women were found in
Scotland (men 21.9%/year, women 20.6%/year) and
Northern Ireland (men no change, women 20.8%/year).
These results differ from the MONICA study that reported
an upward trend in age standardized incidence of major cor-
onary events in Glasgow (men 1.4%, women 0.2%), and
much greater annual relative declines in age standardized inci-
dence of major coronary events in Belfast (men 24.6%/
year, women 21.4%/year). However, the MONICA study
was completed in a much younger population (aged 35–64
years) and in an earlier time period (from the mid-1980s to
the 1990s). Hence, these differences along with differences in
the case deﬁnition of major coronary events (MONICA
study deﬁnition includes coronary death) render direct com-
parisons of trends rather difﬁcult.
The crude risk of death within 30 days following a ﬁrst
incident MI was greater in Scotland compared with
England, although the difference was not statistically signiﬁ-
cant after controlling for explanatory variables. A greater
case fatality in Scotland may reﬂect underlying differences in
the prevalence of risk factors, in particular a higher preva-
lence of smoking.27 Constituent country differences in case
fatality may also reﬂect differences in acute coronary care.
For example, in the MONICA study populations over the
period 1988–1993, higher case fatality in Glasgow com-
pared with Belfast was attributed to the shorter delay
between coronary event onset and access to care in Belfast,
as well as other differences in coronary care pathways.15
In Wales, 30-day case fatality among men declined to
lower than that found in England from 2001 to 2005.
Caution is needed when interpreting this result. One might
consider that poorer death recording by general practices in
Wales might lead to an artefactual downward trend in case
fatality in our data. However, in supplementary analyses we
found the number of deaths recorded by GPs in Wales was
consistent with the number of expected according to
national mortality statistics and the demographic structure
of the GP population over this period. Changes in short-
term case fatality is more likely to reﬂect access to medical
care and rapid treatment as well as changes in diagnostic
thresholds, rather than changes in risk behaviours. One
might consider the devolution of the National Assembly for
Wales in 1999 and the respective introduction of the
National Service Frameworks for CHD in England in 2000
and Wales in 2002 to have contributed to regional variations
in case fatality trends, but the key aims and objectives of
these frameworks were similar.11,12 The sharp downward
trend in case fatality in Wales from 2001 warrants further
investigation before conclusions can be drawn.
Limitations of this study
The representativeness and generalizability of the data from
each constituent country may be questioned. General prac-
tices voluntarily electing to participate in THIN, thus exclud-
ing patients who are not registered with a general practice
participating in THIN. However, 99% of the total UK
population is registered with an NHS GP,28 and the age and
sex distribution of the population within each constituent
country in THIN was shown to be representative of each
country’s population. External validation of the MI inci-
dence estimates for Scotland showed rates in THIN were
comparable to that reported by the Information Services
Division for men and women aged 45–64 years in 2000
(men, 4.5 per 1000; women, 1.48 per 1000) and 2005 (men,
3.5 per 1000; women, 1.17 per 1000).29
MI diagnosis and death in a patient’s primary care record is
usually based on a hospital discharge letter or a diagnosis
made directly by the general practitioner, and then recorded
onto the database using READ codes. MI incidence may be
under-estimated if a diagnosis is not recorded on the patients’
electronic record, or over-estimated if there is retrospective
recording of past MI events in newly registered patients.
However, numerous studies have conﬁrmed the validity of MI
and death recording in primary care databases16,30–32 and have
used THIN to investigate risk factors for MI.33,34 In GPRD, a
primary care database comparable to THIN,16 recording of an
MI event could be conﬁrmed by supporting evidence else-
where in the medical records in 87% of patients,31 and deﬁn-
ing MI events using READ codes had a positive predictive
value of 93% with the electronic event date recorded within 15
days of the actual event date in 90% of cases.32 Validity of MI
diagnosis in THIN had been reported to be over 95%.35–37 In
this study, exploratory analysis demonstrated exclusion of MI
events recorded within the ﬁrst month after patient registration
date limited the effect of retrospective recording of past MI
events in newly registered patients.
The validity of case fatality trends relies upon the accuracy
of recording patient death and the date of death. In a
primary care database death rates may be under-estimated
due to under-recording of patient death, but the all cause
mortality rate in THIN is comparable with national esti-
mates (in 2000; THIN 10.29 per 1000 population, UK
10.33 per 1000).17 Case fatality may be under-estimated if
the death is not recorded on the patient record, or the date
of death is incorrect (i.e. not within 30 days). To prevent
such survivor bias in this analysis, MI events recorded
136 JOURNAL OF PUBLIC HEALTH
before the general practice acceptable mortality reporting
year were excluded.21 Over the study period, there have
been changes to the clinical criteria used to deﬁne an MI
event,38 which may effect case fatality estimates.39 It may be
considered that downward trends in case fatality are due to
increased recording of milder MI events, but if this was true
then an increase in the recording of MIs would be expected.
Our results indicate the opposite: marked declines in case
fatality accompanied by downward trends in the incidence
of ﬁrst MI. Lastly, information on a patients’ history of
chronic disease and risk behaviour may not be recorded on
the patient record. This may under-estimate the proportion
of patients with a history of disease and weakens the associ-
ation between explanatory variables and 30-day case fatality.
What is already known on this topic
Downward trends in acute coronary event rates and
1-month case fatality over the 1990s have been reported in
some UK populations.4–6 However an understanding of
geographical variations in MI incidence and case fatality
relies upon comparing results from a number of individual
studies carried out in localized areas of the UK, making
comparison difﬁcult due to the variety of case deﬁnitions
and populations investigated.14,15
What this study adds
The strength of this research is that it is the ﬁrst population-
based study to examine the trends in the incidence of ﬁrst
MI and 30-day case fatality in men and women across all
four UK constituent countries using a single data set. Over
the period 1996–2005, downward trends in the incidence of
ﬁrst MI and 30-day case fatality are evident in each constitu-
ent country of the UK. Greater improvements in 30-day
case fatality compared with incidence of MI were found in
each constituent country, which may reﬂect greater improve-
ments in acute coronary care than changes to underlying
risk behaviours and CHD prevention.
Future information on constituent-country speciﬁc trends
will be of increasing interest, following devolution of the
governing of health across the four constituent countries of
the UK.
Ethical approval was granted by the South East
Multi-Centre Research Ethics Committees and the London
School of Hygiene and Tropical Medicine Ethics Committee.
Acknowledgements
The authors thank the Epidemiology and Pharmacology
Information Core for providing access to The Health
Improvement Network (THIN) database. We also wish to
that the Economic and Social Research Council for provid-
ing funding for the PhD Scholarship for A.R.D.
Funding
This work was supported by the Economic and Social
Research Council (A.R.D.); and the London School of
Hygiene and Tropical Medicine (E.G. and D.N.); and a
Senior Research Fellowship in Clinical Science from The
Wellcome Trust (L.S.). The authors’ work was independent
of the funders and the funding source had no involvement.
References
1 Allender S, Peto V, Scarborough P et al. Coronary Heart Disease
Statistics. London: British Heart Foundation, 2007.
2 Charlton J, Murphy M, Khaw KT et al. Cardiovascular disease. In:
Charlton J, Murphy MB (eds). The Health of Adult Britain, 1841–
1994. London: The Stationary Ofﬁce, 1997, 60–81.
3 Scarborough P, Allender S, Peto V et al. Regional and social differences
in Coronary Heart Disease. London: British Heart Foundation, 2008.
4 Tunstall-Pedoe H, Kuulasamaa K, Ma¨ho¨nen M et al. Contribution
of trends in survival and coronary-events rates to changes in coron-
ary heart disease mortality: 10 years results from 37 WHO
MONICA Project populations. Lancet 1999;353:1547–57.
5 Lampe FC, Morris RW, Walker M et al. Trends in rates of different
forms of diagnosed coronary heart disease, 1978 to 2000: prospec-
tive, population based study of British men. BMJ 2005;
330(7499):1046–9.
6 Capewell S, Livingston BM, MacIntyre K et al. Trends in case-
fatality in 117718 patients admitted with acute myocardial infarction
in Scotland. Eur Heart J 2000;21(22):1833–40.
7 Ofﬁce of Public Sector Information. Government of Wales Act 1998
(c. 38), 1998.
8 Ofﬁce of Public Sector Information. Scotland Act, 1998.
9 Ofﬁce of Public Sector Information. Northern Ireland (Elections) Act,
1998.
10 Ofﬁce of Public Sector Information. The Northern Ireland Act 2000
(Restoration of Devolved Government) Order, 2007.
11 Department of Health. Coronary Heart Disease: National Service
Framework for Coronary Heart Disease—Modern Standards and Service
Models. London: Department of Health, 2000.
12 The National Assembly for Wales. Tackling CHD in Wales:
Implementing Through Evidence. Cardiff: National Assembly for Wales,
2001.
13 The Scottish Ofﬁce. Coronary Heart Disease and Stroke: Strategy for
Scotland. In: Ofﬁce TS (eds). Edinburgh: The Scottish Ofﬁce, 2002.
14 Norris RM on behalf of the United Kingdom Heart Attack Study
Collaborative Group. Fatality outside hospital from acute coronary
events in three British health districts, 1994–5. BMJ
1998;316(7137):1065–70.
CONSTITUENT COUNTRY INEQUALITIES IN MYOCARDIAL INFARCTION 137
15 Moore W, Kee F, Evans A et al. Pre-hospital coronary care and cor-
onary fatality in the Belfast and Glasgow MONICA populations. Int
J Epidemiol 2005;34(2):422–30.
16 Lewis JD, Schinnar R, Bilker WB et al. Validation studies of the
health improvement network (THIN) database for pharmacoepide-
miology research. Pharmacoepidemiol Drug Saf 2006;16(4):393–401.
17 Bourke A, Dattani H, Robinson M. Feasibility study and method-
ology to create a quality-evaluated database of primary care data.
Inform Prim Care 2004;12:171–7.
18 Ofﬁce for National Statistics. Population Estimates for UK, England and
Wales. Scotland and Northern Ireland, 2006.
19 Department of Health. New GMS Contract QOF Implementation:
Dataset and Business Rules—Coronary Heart Disease Indicator Set,
Version 5. London: Department of Health, 2004,32.
20 Lewis JD, Bilker WB, Weinstein RB et al. The relationship between time
since registration and measured incidence rates in the General Practice
Research Database. Pharmacoepidemiol Drug Saf 2005;14:443–51.
21 Maguire A, Blak BT, Thompson M. The importance of deﬁning
periods of complete mortality reporting for research using auto-
mated data from primary care. Pharmacoepidemiol Drug Saf
2009;18:76–83.
22 British Medical Association and Royal Pharmaceutical Society of
Great Britain. British National Formulary. London: British Medical
Association and Royal Pharmaceutical Society of Great Britain,
2005.
23 Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality
and the North. London: Croom Helm, 1988.
24 Ofﬁce for National Statistics. T01. Mid-2004 Population Estimates:
United Kingdom; Estimated Resident Population by Single Year of Age and Sex;
revised due to Harrow Correction. Ofﬁce for National Statistics, 2005.
25 Kirkwood BR, Sterne JA. Standardisation. In: Kirkwood BR, Sterne
JA (eds). Essential Medical Statistics, 2nd edn. Oxford: Blackwell
Publishing Ltd, 2003,263–71.
26 Leyland A, Goldstein H. Multilevel Modelling of Health Statistics, 1st
edn. Chichester: John Wiley & Sons, 2001.
27 Ofﬁce for National Statistics. Regional Trends. In: Phillpotts G,
Causer P (eds). London: Ofﬁce for National Statistics, 2006.
28 European Observatory on Health Care Systems. Health Care Systems
in Transition. United Kingdom: European Observatory on Health
Care Systems, 1999.
29 Information Services Division NHS Scotland. http://www.
isdscotland.org/isd/5779.html (9 April 2010, date last accessed).
30 Jick H, Derby LE, Gurewich V et al. The risk of myocardial
infarction associated with antihypertensive drug treatment in
persons with uncomplicated essential hypertension. Pharmacotherapy
1996;16:321–6.
31 Jick H, Jick S, Derby L. Validation of information recorded on
general practitioner based computerised data resource in the United
Kingdom. BMJ 1991;302(6779):766–8.
32 Hammad TA, McAdams MA, Feight A et al. Determining the pre-
dictive value of Read/OXMIS codes to identify incident acute myo-
cardial infarction in the General Practice Research Database.
Pharmacoepidemiol Drug Saf 2008;12:1197–201.
33 Hubbard R, Lewis S, Smith C et al. Use of nicotine replacement
therapy and the risk of acute myocardial infarction, stroke, and
death. Tob Control 2005;14(6):416–21.
34 Donaldson GC, Hurst JR, Smith CJ et al. Increased risk of myocar-
dial infarction and stroke following exacerbation of chronic obstruc-
tive pulmonary disease. Chest 2009, doi: 10.1378/chest.09-2029.
35 Garcia Rodriguez LA, Varas C, Patrono C. Differential effects of
aspirin and non-aspirin nonsteroidal antiinﬂammatory drugs in the
primary prevention of myocardial infarction in postmenopausal
women. Epidemiology 2000;11(4):382–7.
36 Garcia Rodriguez LA, Varas-Lorenzo C, Maguire A et al.
Nonsteroidal anti-inﬂammatory drugs and the risk of myocardial
infarction in the general population. Circulation 2004;109(24):
3000–6.
37 Garcia Rodrıguez LA, Tacconelli S, Patrignani P. Role of dose
potency in the prediction of risk of myocardial infarction associated
with nonsteroidal anti-inﬂammatory drugs in the general population.
J Am Coll Cardiol 2008;52:1628–36.
38 Joint European Society of Cardiology/American College of
Cardiology Committee for the Redeﬁnition of Myocardial
Infarction. Myocardial infarction redeﬁned—a consensus document
of The Joint European Society of Cardiology/American College of
Cardiology Committee for the Redeﬁnition of Myocardial
Infarction. Eur Heart J 2000;21(18):1502–13.
39 Packham C, Gray D, Weston C et al. Changing the diagnostic criteria
for myocardial infarction in patients with a suspected heart attack
affects the measurement of 30 day mortality but not long term sur-
vival. Heart 2002;88(4):337–42.
138 JOURNAL OF PUBLIC HEALTH
